Healthcare - Biotechnology - NASDAQ - US
$ 0.043
3.61 %
$ 2.34 M
Market Cap
-0.09
P/E
INCOME STATEMENT
0
REVENUE
-47 M
OPERATING INCOME
-59.1 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Galera Therapeutics, Inc.
| Revenue | 0 |
| Cost Of Revenue | 259 K |
| Gross Profit | -259 K |
| Operating Expenses | 47 M |
| Operating Income | -47 M |
| Other Expenses | 12.1 M |
| Net Income | -59.1 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|
| REVENUE | |||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| GROSS PROFIT | |||||||
| Cost Of Revenue | 0.3 | 0.1 | 0.8 | 0.4 | 0.3 | 0.1 | 84 K |
| Gross Profit | (0.3) | (0.1) | (0.8) | (0.4) | (0.3) | (0.1) | 84 K |
| OPERATING INCOME | |||||||
| Operating Expenses | 47.0 | 51.2 | 73.4 | 70.6 | 50.7 | 24.3 | 24.1 |
| Selling, General and Administrative Expenses | 22.8 | 20.2 | 21.0 | 15.7 | 8.4 | 5.6 | 3.5 |
| Research and Development Expenses | 24.1 | 31.0 | 52.4 | 54.8 | 42.3 | 18.7 | 20.6 |
| Operating Income | (47.0) | (51.2) | (73.4) | (70.6) | (50.7) | (24.3) | (24.1) |
| PRE-TAX INCOME | |||||||
| Interest Income Expense | (11.4) | 11.6 | 7.2 | 4.9 | 3.0 | 0.2 | 0 |
| Total Other Income | (12.1) | (11.1) | (7.2) | (3.7) | (1.2) | 0.4 | 0.2 |
| Pre-Tax Income | (59.1) | (62.3) | (80.5) | (74.2) | (51.9) | (23.9) | (23.9) |
| NET INCOME | |||||||
| Tax Provision | 0 | 70 K | 7.2 | 16 K | 9 K | (0.2) | (0.4) |
| Net Income | (59.1) | (62.2) | (87.7) | (74.2) | (51.9) | (23.7) | (23.5) |
| EPS | 1.33 | 2.3 | 3.4 | 2.98 | 2.09 | 1.22 | 1.55 |